Статья
ЗАСТОЙНАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ - ВОЗМОЖНО ЛИ ПРОДЛИТЬ ЖИЗНЬ ПАЦИЕНТА?
Рассматриваются результаты исследований, посвященных оценке влияния медикаментозной терапии, имплантации кардиовертеров-дефибрилляторов и ресинхронизирующей терапии на смертность больных с застойной сердечной недостаточностью.
1. Bardy G.H., Lee K.L., Mark D.B., et al. Sudden Cardiac Death-Heart Failure Trial (SCDHeFT). In: Woosley R.L., Singh S.N., eds. Arrhythmia treatment and therapy: evaluation of clinical trial evidence. New York: Marcel Dekker, 2000: 323-42.
2. Bristow M.R., Feldman A.M., Saxon L.A. Heart failure management using implantable devices for intraventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) Trial. J Card Fail 2000; 6: 276-85.
3. Cairns J.A., Connolly S.J., Roberts R., Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-82. [Erratum, Lancet 1997; 349: 1776.]
4. Julian D.G., Camm A.J., Frangin G., et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 667-74. [Errata, Lancet 1997; 349: 1180, 1776.]
5. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-8.
6. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
7. Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102: 3053-9. [Erratum, Circulation 2001; 103: 476.]
8. Singh S.N., Fletcher R.D., Gross Fisher S., et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
9. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-84.
10. Moss A.J., Zareba W., Hall W.J., et al; the Multicenter Automatic Defibrillator Implantation Trial II investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877.
11. Doval H.C., Nul D.R., Grancelli H.O., et al: Randomised trial of low dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994; 344: 493.
12. Singh S.N., Fletcher R.D., Fisher S.G., et al: the Survival Trial of Antiarrhytmic Therapy in Congestive Heart Failure: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. New Engl J Med 1995; 333: 77.
13. Katz A.M.: Physiology of the Heart. Third edition 2000; 658-688.
14. Бокерия Л.А., Ревишвили А.Ш., Неминущий H.M., Ефимов И.Р. Имплантируемые кардиовертеры - дефибрилляторы. - M., 2005.
15. Бокерия Л.А., Ревишвили А.Ш., Ардашев А.В., Кочович Д.З. Желудочковые аритмии. - M., 2002.